{
    "summary": "The bill, titled the Enhancing Domestic Drug Manufacturing Competitiveness Act, directs the Comptroller General of the United States to conduct a study. This study will identify and assess regulatory barriers that hinder the expansion or establishment of new pharmaceutical manufacturing facilities in the United States, comparing them to other countries. The study will also explore technological solutions. The Comptroller General will engage stakeholders and submit a report to Congress within a year, including recommendations for streamlining regulations and promoting manufacturing growth.",
    "tags": [
        "Healthcare",
        "Economic recovery",
        "Trade policy",
        "Job creation",
        "Healthcare access",
        "Opioid crisis"
    ],
    "category": "Healthcare & Public Health"
}